Corbus Pharmaceuticals Holdings, Inc. (CRBP)
5.85
-0.28
(-4.57%)
USD |
NASDAQ |
Oct 05, 16:00
5.85
0.00 (0.00%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Market Cap : 109.23M for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 114.46M |
| October 01, 2026 | 118.38M |
| September 30, 2026 | 127.34M |
| September 29, 2026 | 123.79M |
| September 28, 2026 | 129.21M |
| September 25, 2026 | 133.31M |
| September 24, 2026 | 139.10M |
| September 23, 2026 | 144.52M |
| September 22, 2026 | 147.04M |
| September 21, 2026 | 142.84M |
| September 18, 2026 | 139.66M |
| September 17, 2026 | 135.56M |
| September 16, 2026 | 135.56M |
| September 15, 2026 | 129.21M |
| September 14, 2026 | 150.87M |
| September 11, 2026 | 151.61M |
| September 10, 2026 | 153.85M |
| September 09, 2026 | 165.43M |
| September 08, 2026 | 197.82M |
| September 04, 2026 | 206.88M |
| September 03, 2026 | 213.98M |
| September 02, 2026 | 214.35M |
| September 01, 2026 | 210.61M |
| August 31, 2026 | 203.71M |
| August 28, 2026 | 203.71M |
| Date | Value |
|---|---|
| August 27, 2026 | 207.81M |
| August 26, 2026 | 210.99M |
| August 25, 2026 | 211.17M |
| August 24, 2026 | 199.60M |
| August 21, 2026 | 193.81M |
| August 20, 2026 | 183.73M |
| August 19, 2026 | 186.53M |
| August 18, 2026 | 188.21M |
| August 17, 2026 | 195.86M |
| August 14, 2026 | 188.40M |
| August 13, 2026 | 188.21M |
| August 12, 2026 | 182.23M |
| August 11, 2026 | 177.57M |
| August 10, 2026 | 176.63M |
| August 07, 2026 | 189.89M |
| August 06, 2026 | 181.86M |
| August 05, 2026 | 178.69M |
| August 04, 2026 | 175.51M |
| August 03, 2026 | 158.23M |
| July 31, 2026 | 159.12M |
| July 30, 2026 | 160.54M |
| July 29, 2026 | 158.23M |
| July 28, 2026 | 161.16M |
| July 27, 2026 | 161.07M |
| July 24, 2026 | 162.67M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.460B |
| Alnylam Pharmaceuticals, Inc. | 29.41B |
| Savara, Inc. | 982.84M |
| Vericel Corp. | 2.104B |
| Biogen, Inc. | 33.01B |
Market Cap Related Metrics
| PEG Ratio | -0.0320 |
| Price to Book Value | 1.068 |
| Price | 5.85 |
| Earnings Yield | -105.6% |
| PEGY Ratio | -0.0320 |